Connect with us

Science

California’s Plan for Cheaper Insulin Collides With Big Pharma’s Price Cuts

Published

on

California’s Plan for Cheaper Insulin Collides With Big Pharma’s Price Cuts

California is shifting forward with its plan to supply state-sponsored insulin, however its objective of providing cheaper medication than brand-name firms could also be a lot more durable to attain now that these main drug makers have determined to considerably drop sticker costs on some merchandise.

So whereas some specialists welcomed the information final weekend that the state had awarded a $50 million contract to Civica, a nonprofit group, to fabricate low-cost insulin, others questioned if the initiative remained viable given the altering market. Civica’s deliberate merchandise would nonetheless want federal approval, which suggests it may take a minimum of two years earlier than they develop into out there on the market.

For years, the excessive prices related to insulin for individuals with diabetes have compelled some to ration their medicines, jeopardizing their well being.

For the estimated eight million Individuals with diabetes who want insulin, together with about a million Californians, the typical value has greater than quadrupled in 20 years. There have been wild variations in pricing, nevertheless, with Eli Lilly elevating the sticker value of its hottest product, Humalog, greater than tenfold.

Many individuals with personal medical insurance pay nothing or not more than a $20 to $35 co-payment for a month-to-month insulin provide. And since January, the Inflation Discount Act has imposed a $35 value cap for the practically 4 million insulin customers with Medicare Half D.

Advertisement

However these with high-deductible well being plans or the uninsured — an estimated 12 p.c and seven p.c, respectively, of California’s insulin customers — usually face a lot greater prices, costing them a whole bunch of {dollars} monthly.

“It is a house the place seemingly all people appears to be making a fast buck,” Gov. Gavin Newsom stated on March 18 at a information convention saying the brand new pharmaceutical contract in Downey, Calif., earlier than a backdrop of insulin-stocked fridges. “Time for disruption.”

Mr. Newsom, who was on a four-day state tour to advertise his insurance policies, additionally introduced plans for California to develop its personal naloxone, which reverses opioid overdose.

The insulin contract is the result of the state Legislature’s appropriation final 12 months of $100 million for this system, referred to as the CalRx Biosimilar Insulin Initiative. (Competitor variations of so-called biologic remedies like insulin are often called biosimilars.) Beneath the 10-year deal, Civica stated it deliberate to develop and produce these merchandise at a brand new plant in Petersburg, Va., and would start submitting functions for approval of the biosimilar merchandise with the Meals and Drug Administration subsequent 12 months. Half of the $100 million finances would go towards establishing a California plant for additional manufacturing.

The biosimilar variations are anticipated to be corresponding to Eli Lilly’s Humalog, Novo Nordisk’s NovoLog and Sanofi’s Lantus. These three firms management about 90 p.c of the insulin market.

Advertisement

Eli Lilly, Sanofi and Novo Nordisk have introduced sticker-price cuts, largely within the 70 p.c vary, and a few caps on out-of-pocket prices for sure insulin merchandise. The decrease costs ought to start late this 12 months into subsequent 12 months, relying on the corporate.

President Biden and Democratic lawmakers have taken credit score for the drug makers’ strikes, however the firms had fewer monetary incentives to maintain costs excessive on their older insulin merchandise, they usually now rely extra on newer medicine for diabetes and weight problems. The drug makers additionally have been dealing with penalties that might have compelled them to pay Medicaid again for elevating their costs quicker than inflation.

Civica was based in 2018 by a collective of well being methods in search of to mitigate continual drug shortages. Ned McCoy, chief government of Civica, stated the corporate introduced its pricing a 12 months in the past “with the objective of forcing the market to reply.”

Whereas many tutorial specialists in insulin pricing expressed optimism about California’s transfer, some remained skeptical that its plans and others in early phases in Maine, Michigan and Washington may dwell as much as their hype.

Andrew Mulcahy, a senior coverage researcher on the RAND Company whose 2020 examine discovered the typical U.S. checklist value for insulin was 10 occasions that of different nations, was measured in his evaluation.

Advertisement

“It’s one essential change in a time the place there’s loads in flux for insulin,” he stated. “There’s potential for financial savings for Californians and others. But it surely’s not clear that is going to basically change the market. It already has in some methods. There are already these cheaper options which can be cropping up available in the market.”

He famous that Walmart sells a store-brand model of NovoLog, referred to as ReliOn, for about $73 per vial. And the checklist value for a vial of NovoLog, a broadly used product, will drop to $72, from $289, in accordance with Novo Nordisk’s plan.

CalRx will set really useful most retail costs of $30 for a 10-milliliter insulin vial and $55 for a set of 5 prefilled 3-milliliter pens. California residents will likely be given precedence for the availability.

Whether or not Civica’s insulin will likely be that less expensive than the big-brand names as soon as the brand new value cuts are imposed is open for debate, particularly as Civica’s merchandise received’t be out there anytime quickly.

Earlier than the brand new cuts have been introduced, a JAMA editorial recommended {that a} profitable launch may present a potent mannequin for state-driven disruption of the pharmaceutical trade.

Advertisement

“The perfect-case situation is that the CalRx plan gives some sunshine on a path ahead to state interventions in curbing drug costs,” Jacob S. Sherkow, a professor of regulation and medication on the College of Illinois Urbana-Champaign and the editorial’s lead writer, stated.

“Loads of earlier makes an attempt in that space have simply failed fully, both by dint of economics or by authorized challenges,” Mr. Sherkow continued. “That is a method that states can get again within the enterprise of offering public items.”

A number of states’ attorneys common, together with California’s, not too long ago filed swimsuit towards the three huge insulin drug makers over excessive costs, and likewise towards pharmacy profit managers — firms that negotiate reductions off sticker costs on behalf of insurers, pocketing a few of the distinction.

California’s generic drug plan would prohibit pharmacy profit managers from profiting off rebates, undermining what critics cost is a relationship between the businesses and the drug makers that’s imbued with a perverse incentive to inflate sticker costs.

Reid Porter, a consultant for PhRMA, the foremost commerce group for drug firms, joined a Sanofi consultant in pointing the finger at pharmacy profit managers for, they stated, not passing financial savings on to the patron.

Advertisement

Mr. Newsom, Mr. Porter stated, “needs to attain political factors and villainize the trade chargeable for making California a worldwide chief in creating lifesaving remedies and cures and infusing greater than $200 billion into the financial system and supporting practically 700,000 jobs.”

Reached for touch upon the California program, representatives for Eli Lilly and Novo Nordisk highlighted their plans to decrease a few of their insulin costs.

On the information convention, Mr. Newsom stated, “I believe it could be spectacular if all these different firms fell even additional of their value concerns and dropped effectively beneath” the state’s value factors. He expressed confidence that Civica may “dynamically tackle” such underselling.

Nonetheless, the latest modifications will imply many Californians with diabetes will almost definitely be capable to spend much less on their insulin subsequent 12 months.

As soon as the three pharmaceutical firms’ new reductions are in place, annual out-of-pocket prices for people who find themselves uninsured or have high-deductible plans and who use the three merchandise that the California program seeks to copy would vary from $420 to $1,200, in accordance with Dr. Mariana Socal, an affiliate scientist on the Johns Hopkins Bloomberg Faculty of Public Well being.

Advertisement

The state program is anticipated to cost these people $200 to $375 a 12 months for its variations of those merchandise. Annual prices for well-insured individuals would drop from about $350 to $550 at the moment all the way down to $140 to $250 due to this system.

Baylee Bakkila, a Yale College medical scholar, led a examine revealed in Well being Affairs in July discovering that 14 p.c of insulin customers spent greater than 40 p.c of their disposable earnings on the drug.

Ms. Bakkila has reservations in regards to the California program, noting that the costs are set by the insulin vial or set of pens, not a set month-to-month payment. She pointed to the Medicare value cap; Eli Lilly’s comparable $35 cap for a month-to-month insulin provide, which is often two to 3 vials; and Sanofi’s plan for a comparable cap.

“CalRx will present advantages to sufferers spending exorbitantly on insulin,” Ms. Bakkila stated of the estimated 190,000 Californians with high-deductible plans or no insurance coverage. “However, by comparability, these packages already in place lower spending much more.”

Niketa Calame-Harris, 42, is an actress, performing trainer and advocate for the American Diabetes Affiliation whose Kind 1 diabetes was identified in school. A resident of Los Angeles, she is roofed by an Obamacare personal well being plan, and he or she pays about $5,000 a 12 months for Humalog insulin. She stated she had needed to ration her doses at occasions.

Advertisement

She anticipated she would save about $3,000 a 12 months beneath the state plan. However she may save about $3,500 a 12 months as soon as Eli Lilly’s lower goes into impact within the final three months of this 12 months. And probably extra if she is eligible for its $35 cap.

Anticipating the financial savings, Ms. Harris considered her 2-year-old daughter and stated, “That cash may go towards her getting a greater training.”

Rebecca Robbins contributed to this text.

Advertisement
Continue Reading
Advertisement
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Science

Opinion: America's 'big glass' dominance hangs on the fate of two powerful new telescopes

Published

on

Opinion: America's 'big glass' dominance hangs on the fate of two powerful new telescopes

More than 100 years ago, astronomer George Ellery Hale brought our two Pasadena institutions together to build what was then the largest optical telescope in the world. The Mt. Wilson Observatory changed the conception of humankind’s place in the universe and revealed the mysteries of the heavens to generations of citizens and scientists alike. Ever since then, the United States has been at the forefront of “big glass.”

In fact, our institutions, Carnegie Science and Caltech, still help run some of the largest telescopes for visible-light astronomy ever built.

But that legacy is being threatened as the National Science Foundation, the federal agency that supports basic research in the U.S., considers whether to fund two giant telescope projects. What’s at stake is falling behind in astronomy and cosmology, potentially for half a century, and surrendering the scientific and technological agenda to Europe and China.

In 2021, the National Academy of Sciences released Astro2020. This report, a road map of national priorities, recommended funding the $2.5-billion Giant Magellan Telescope at the peak of Cerro Las Campanas in Chile and the $3.9-billion Thirty Meter Telescope at Mauna Kea in Hawaii. According to those plans, the telescopes would be up and running sometime in the 2030s.

NASA and the Department of Energy backed the plan. Still, the National Science Foundation’s governing board on Feb. 27 said it should limit its contribution to $1.6 billion, enough to move ahead with just one telescope. The NSF intends to present their process for making a final decision in early May, when it will also ask for an update on nongovernmental funding for the two telescopes. The ultimate arbiter is Congress, which sets the agency’s budget.

Advertisement

America has learned the hard way that falling behind in science and technology can be costly. Beginning in the 1970s, the U.S. ceded its powerful manufacturing base, once the nation’s pride, to Asia. Fast forward to 2022, the U.S. government marshaled a genuine effort toward rebuilding and restarting its factories — for advanced manufacturing, clean energy and more — with the Inflation Reduction Act, which is expected to cost more than $1 trillion.

President Biden also signed into law the $280-billion CHIPS and Science Act two years ago to revive domestic research and manufacturing of semiconductors — which the U.S. used to dominate — and narrow the gap with China.

As of 2024, America is the unquestioned leader in astronomy, building powerful telescopes and making significant discoveries. A failure to step up now would cede our dominance in ways that would be difficult to remedy.

The National Science Foundation’s decision will be highly consequential. Europe, which is on the cusp of overtaking the U.S. in astronomy, is building the aptly named Extremely Large Telescope, and the United States hasn’t been invited to partner in the project. Russia aims to create a new space station and link up with China to build an automated nuclear reactor on the moon.

Although we welcome any sizable grant for new telescope projects, it’s crucial to understand that allocating funds sufficient for just one of the two planned telescopes won’t suffice. The Giant Magellan and the Thirty Meter telescopes are designed to work together to create capabilities far greater than the sum of their parts. They are complementary ground stations. The GMT would have an expansive view of the southern hemisphere heavens, and the TMT would do the same for the northern hemisphere.

Advertisement

The goal is “all-sky” observation, a wide-angle view into deep space. Europe’s Extremely Large Telescope won’t have that capability. Besides boosting America’s competitive edge in astronomy, the powerful dual telescopes, with full coverage of both hemispheres, would allow researchers to gain a better understanding of phenomena that come and go quickly, such as colliding black holes and the massive stellar explosions known as supernovas. They would put us on a path to explore Earth-like planets orbiting other suns and address the question: “Are we alone?

Funding both the GMT and TMT is an investment in basic science research, the kind of fundamental work that typically has led to economic growth and innovation in our uniquely American ecosystem of scientists, investors and entrepreneurs.

Elon Musk’s SpaceX is the most recent example, but the synergy goes back decades. Basic science at the vaunted Bell Labs, in part supported by taxpayer contributions, was responsible for the transistor, the discovery of cosmic microwave background and establishing the basis of modern quantum computing. The internet, in large part, started as a military communications project during the Cold War.

Beyond its economic ripple effect, basic research in space and about the cosmos has played an outsized role in the imagination of Americans. In the 1960s, Dutch-born American astronomer Maarten Schmidt was the first scientist to identify a quasar, a star-like object that emits radio waves, a discovery that supported a new understanding of the creation of the universe: the Big Bang. The first picture of a black hole, seen with the Event Horizon Telescope, was front-page news in 2019.

We understand that competing in astronomy has only gotten more expensive, and there’s a need to concentrate on a limited number of critical projects. But what could get lost in the shuffle are the kind of ambitious projects that have made America the scientific envy of the world, inspiring new generations of researchers and attracting the best minds in math and science to our colleges and universities.

Advertisement

Do we really want to pay that price?

Eric D. Isaacs is the president of Carnegie Science, prime backer of the Giant Magellan Telescope. Thomas F. Rosenbaum is president of Caltech, key developer of the Thirty Meter Telescope.

Continue Reading

Science

Mosquito season is upon us. So why are Southern California officials releasing more of them?

Published

on

Mosquito season is upon us. So why are Southern California officials releasing more of them?

Jennifer Castellon shook, tapped and blew on a box to shoo out more than 1,000 mosquitoes in a quiet, upscale Inland Empire neighborhood.

The insects had a job to do, and the pest scientist wanted every last one out.

Aggressive and impactful reporting on climate change, the environment, health and science.

Advertisement

Their task? Find lady mosquitoes and mate.

But these were no ordinary mosquitoes. Technicians had zapped the insects, all males, with radiation in a nearby lab to make them sterile. If they achieve their amorous quest, there will be fewer baby mosquitoes than there would be if nature ran its course. That means fewer mouths to feed — mouths that thirst for human blood.

“I believe, fingers crossed, that we can drop the population size,” said Solomon Birhanie, scientific director for the West Valley Mosquito and Vector Control District, which released the mosquitoes in several San Bernardino County neighborhoods this month.

Sterilized male mosquitoes flying out of a box in Rancho Cucamonga

Sterilized male Aedes mosquitoes are released from a box in Rancho Cucamonga.

(Myung J. Chun / Los Angeles Times)

Advertisement

Controlling mosquitoes with mosquitoes

Mosquito control agencies in Southern California are desperate to tamp down an invasive mosquito — called Aedes aegypti — that has exploded in recent years. Itchy, unhappy residents are demanding it. And the mosquitoes known for fierce ankle biting aren’t just putting a damper on outdoor hangouts — they also spread disease.

The low-flying, day-biting mosquitoes can lay eggs in tiny water sources. A bottle cap is fair game. And they might lay a few, say, in a plant tray and others, perhaps, in a drain. Tackling the invaders isn’t easy when it can be hard to even locate all the reproduction spots. So public health agencies increasingly are trying to use the insects’ own biology against them by releasing sterilized males.

The West Valley district, which covers six cities in San Bernardino County, rolled out the first program of this kind in California last year. Now they’re expanding it. Next month, a vector district covering a large swath of Los Angeles County will launch its own pilot, followed by Orange County in the near future. Other districts are considering using the sterile insect technique, as the method is known, or watching early adopters closely.

On the plus side, it’s an approach that doesn’t rely on pesticides, which mosquitoes become resistant to, but it requires significant resources and triggers conspiracy theories.

“People are complaining that they can’t go into their backyard or barbecue in the summer,” Birhanie said at his Ontario lab. “So we needed something to strengthen our Aedes control.” Of particular concern is the Aedes aegypti, which love to bite people — often multiple times in rapid succession.

Advertisement

Releasing sterilized male insects to combat pests is a proven scientific technique, but using it to control invasive mosquitoes is relatively new.

Vector control experts often point to the success of a decades-long effort in California to fight Mediterranean fruit flies by dropping enormous quantities of sterile males from small planes. That program, run by the U.S. Department of Agriculture and the California Department of Food and Agriculture, costs about $16 million a year. That’s nearly four times West Valley’s annual budget.

So rather than try to tackle every nook and cranny of the district, encompassing roughly 650,000 residents, West Valley decided to use a more targeted approach. If a problem area reaches a certain threshold — over 50 mosquitoes counted in an overnight trap — it becomes a candidate.

1 A man in a lab coat looks at plastic containers of mosquito larvae in a lab.

2 A man in a lab coat with a gloved hand uses an eye dropper in a plastic container with water and mosquito larvae.

3 Mosquito eggs in a lab

4 In the eye-dropper tube, water and mosquito larvae

5 A man in a lab coat demonstrates an X-ray machine that sterilizes the male mosquitoes.

1. Solomon Birhanie inspects a container of mosquito larvae in the lab at the West Valley Mosquito and Vector Control District in Ontario. 2. Birhanie and his team raise mosquitoes in the lab, separating them by sex, because only the males, which don’t bite humans, will eventually be released. 3. Mosquito eggs in the West Valley lab. 4. The lab can grow about 10,000 mosquitoes at a time. 5. Before the male mosquitoes are released, an X-ray machine sterilizes them. If the zapped males mate with a female, her eggs won’t hatch. (Allen J. Schaben / Los Angeles Times)

Advertisement

And it’s still a big lift. About 10,000 mosquitoes are reared at a time at West Valley’s facility, about half of which will be males. The males are separated out, packed into cups and placed into an X-ray machine that looks like a small refrigerator. The sterilizing process isn’t that different from microwaving a frozen dinner. Zap them on a particular setting for four to five minutes and they’re good to go.

Equipment purchased for the program costs roughly $200,000, said Brian Reisinger, spokesperson for the district. He said it was too early to pin down a cost estimate for the program, which is expanding.

Some districts serving more people are going bigger.

The Greater Los Angeles County Vector Control District plans to unleash up to 60,000 mosquitoes a week in two neighborhoods in Sunland-Tujunga from mid-May through November.

Advertisement

With the sterile-insect program, “the biggest hurdle we’re up against really is scalability,” said Susanne Kluh, general manager of the L.A. County district, which is responsible for nearly 6 million residents across 36 cities.

In part to save money, Kluh’s district has partnered with the Orange County Mosquito and Vector Control District. They’re sharing equipment and collaborating on studies, but L.A. County’s releases will move forward first, said Brian Brannon, spokesperson for the O.C. district. Orange County expects to release its “ankle biter fighters,” as Brannon called them, in Mission Viejo this fall or next spring.

So far, the L.A. County district has shelled out about $255,000 for its pilot, while O.C. has spent around $160,000. It’s a relatively small portion of their annual budgets: L.A. at nearly $25 million and O.C. at $17 million. But the area they’re targeting is modest.

Mosquito control experts tout sterilization for being environmentally friendly because it doesn’t involve spraying chemicals, and it may have a longer-lasting effectiveness than pesticides. It can also be done now. Other methods involving genetically modified mosquitoes and ones infected with bacteria are stuck in an approval process that spans federal and state agencies. One technique, involving the bacteria Wolbachia was recently approved by the Environmental Protection Agency and is now heading to the California Department of Pesticide Regulation to review, said Jeremy Wittie, general manager for the Coachella Valley Mosquito and Vector Control District.

“Using pesticides or insecticides, resistance crops up very quickly,” said Nathan Grubaugh, associate professor of epidemiology at the Yale School of Public Health.

Advertisement

Vector control experts hope the fact that the sterilization technique doesn’t involve genetic modification will tamp down conspiracy theories that have cropped up around mosquito releases. One erroneous claim is that a Bill Gates-backed effort to release mosquitoes was tied to malaria cases in Florida and Texas. Reputable outlets debunked the conspiracy theory, pointing out that Gates’ foundation didn’t fund the Florida project and that the type of mosquito released (Aedes) does not transmit malaria.

To get ahead of concerns, districts carrying out the releases say they’ve engaged in extensive outreach and education campaigns. Residents’ desire to rid themselves of a scourge may overcome any anxieties.

“I think if you have the choice of getting eaten alive by ankle biters or having a DayGlo male X-rayed mosquito come by looking for a female to not have babies with, you’d probably go for the latter,” Brannon said. (“DayGlo” is a riff on the fluorescent pigment product of the same name — the sterilized mosquitoes were dusted with bright colors to help identify them.)

Mosquitoes buzz around the face of a woman wearing sunglasses

Sterilized male mosquitoes buzz around vector ecologist Jennifer Castellon as they are released in Rancho Cucamonga earlier this month.

(Myung J. Chun / Los Angeles Times)

Advertisement

Disease at our doorstep

As the climate warms and some regions become wetter, dengue is expanding to areas it’s never been seen before — and surging in areas where it’s established. Florida has seen alarming spikes in the viral infection in recent years, and Brazil and Puerto Rico are currently battling severe outbreaks. While most people infected with dengue have no symptoms, it can cause severe body aches and fever and, in rare cases, death. Its alias, “breakbone fever,” provides a grim glimpse into what it can feel like.

In October of last year, the city of Pasadena announced the Golden State’s first documented locally transmitted case of dengue, describing it as “extremely rare” in a news release. That same month, a second case was confirmed in Long Beach. Local transmission means the patient hadn’t traveled to a region where dengue is common; they may have been bitten by a mosquito carrying the disease in their own neighborhood.

Surging dengue abroad means there’s more opportunity for travelers to bring it home. However, Grubaugh said it doesn’t seem that California is imminently poised for a “Florida-like situation,” where there were nearly 1,000 cases in 2022, including 60 that were locally acquired. Southern California in particular lacks heavy rainfall that mosquitoes like, he said. But some vector experts believe more locally acquired cases are inevitable.

A woman stands under a tree in a residential area, releasing mosquitoes from a box.

Ale Macias releases sterilized male mosquitoes in Upland this month.

(Myung J. Chun / Los Angeles Times)

Advertisement

Set them free

In mid-April, a caravan of staffers from the West Valley district traveled to five mosquito “hot spots” in Chino, Upland and Rancho Cucamonga — where data showed mosquito levels were particularly high — to release their first batches of sterilized male mosquitoes for the year. Peak Aedes season is months away, typically August to October in the district, and Birhanie said that’s the point. The goal is to force down the numbers to prevent an itchy tsunami later.

Males don’t bite, so the releases won’t lead to more inflamed welts. But residents might notice more insects in the air. Sterilized males released by West Valley will outnumber females in the wild by at least 100 to 1 to increase their chances of beating out unaltered males, spokeperson Reisinger said.

“They’re not going to be contributing to the biting pressure; they’re just going to be looking for love,” as Reisinger put it.

Eggs produced by a female after a romp with a sterile male don’t hatch. And female mosquitoes typically mate only once, meaning all her eggs are spoiled, so to speak. Vector experts say the process drives down the population over time.

Interestingly, the hot spots were fairly spread out across the district, indicative of the bloodsuckers’ widespread presence and adaptive nature. A picturesque foothills community in Upland was “especially interesting” because of its relatively high elevation, Birhanie said.

Advertisement

It was once inhabited primarily by another invasive mosquito that prefers colder, mountainous climates. Construction and deforestation in the area has literally paved the way for its humidity- and heat-loving brethren to move in.

Another neighborhood, in Rancho Cucamonga, posed a mystery. For the last two years, mosquito levels were consistently high. Door-to-door inspections, confoundingly, didn’t reveal the source.

“That’s one of the things about invasive Aedes mosquitoes — you can’t find them,” he said.

Next steps

Some vector control experts want to see a regional approach to sterile mosquito releases, similar to the state Medfly program.

Jason Farned, district manager for the San Gabriel Valley Mosquito and Vector Control District, believes a widespread effort “would be much more effective” and thinks that will come in time.

Advertisement

There are no talks underway to make it happen, and it’s not yet clear how it would work. Vector control agencies are set up to serve their local communities.

Fears of a bad mosquito year ahead are bubbling as the weather warms. Rain — which there was plenty of this spring — can quickly transform into real estate for mosquito reproduction.

When the swarms come, mosquito haters can take typical precautions: dump standing water and wear repellent. And they can root for the sterile males to get lucky.

Advertisement
Continue Reading

Science

After months of silence, Voyager 1 has returned NASA's calls

Published

on

After months of silence, Voyager 1 has returned NASA's calls

For the last five months, it seemed very possible that a 46-year-old conversation had finally reached its end.

Since its launch from Kennedy Space Center on Sept. 5, 1977, NASA’s Voyager 1 spacecraft has diligently sent regular updates to Earth on the health of its systems and data collected from its onboard instruments.

But in November, the craft went quiet.

Voyager 1 is now some 15 billion miles away from Earth. Somewhere in the cold interstellar space between our sun and the closest stars, its flight data system stopped communicating with the part of the probe that allows it to send signals back to Earth. Engineers at the Jet Propulsion Laboratory in La Cañada Flintridge could tell that Voyager 1 was getting its messages, but nothing was coming back.

Advertisement

“We’re to the point where the hardware is starting to age,” said Linda Spilker, the project scientist for Voyager mission. “It’s like working on an antique car, from 15 billion miles away.”

Week after week, engineers sent troubleshooting commands to the spacecraft, each time patiently waiting the 45 hours it takes to get a response here on Earth — 22.5 hours traveling at the speed of light to reach the probe, and 22.5 hours back.

By March, the team had figured out that a memory chip that stored some of the flight data system’s software code had failed, turning the craft’s outgoing communications into gibberish.

A long-distance repair wasn’t possible. There wasn’t enough space anywhere in the system to shift the code in its entirety. So after manually reviewing the code line by line, engineers broke it up and tucked the pieces into the available slots of memory.

They sent a command to Voyager on Thursday. In the early morning hours Saturday, the team gathered around a conference table at JPL: laptops open, coffee and boxes of doughnuts in reach.

Advertisement

At 6:41 a.m., data from the craft showed up on their screens. The fix had worked.

“We went from very quiet and just waiting patiently to cheers and high-fives and big smiles and sighs of relief,” Spilker said. “I’m very happy to once again have a meaningful conversation with Voyager 1.”

Voyager 1 is one of two identical space probes. Voyager 2, launched two weeks before Voyager 1, is now about 13 billion miles from Earth, the two crafts’ trajectories having diverged somewhere around Saturn. (Voyager 2 continued its weekly communications uninterrupted during Voyager 1’s outage.)

They are the farthest-flung human-made objects in the universe, having traveled farther from their home planet than anything else this species has built. The task of keeping communications going grows harder with each passing day. Every 24 hours, Voyager 1 travels 912,000 miles farther away from us. As that distance grows, the signal becomes slower and weaker.

When the probe visited Jupiter in 1979, it was sending back data at a rate of 115.2 kilobits per second, Spilker said. Today, 45 years and more than 14 billion miles later, data comes back at a rate of 40 bits per second.

Advertisement

The team is cautiously optimistic that the probes will stay in contact for three more years, long enough to celebrate the mission’s 50th anniversary in 2027, Spilker said. They could conceivably last until the 2030s.

The conversation can’t last forever. Microscopic bits of silica keep clogging up the thrusters that keep the probes’ antennas pointed toward Earth, which could end communications. The power is running low. Eventually, the day will come when both Voyagers stop transmitting data to Earth, and the first part of their mission ends.

But on the day each craft goes quiet, they begin a new era, one that could potentially last far longer. Each probe is equipped with a metallic album cover containing a Golden Record, a gold-plated copper disk inscribed with sounds and images meant to describe the species that built the Voyagers and the planet they came from.

Erosion in space is negligible; the images could be readable for another billion years or more. Should any other intelligent life form encounter one of the Voyager probes and have a means of retrieving the data from the record, they will at the very least have a chance to figure out who sent them — even if our species is by that time long gone.

Advertisement
Continue Reading

Trending